What is the share price of Advanced Enzyme Technologies Ltd (ADVENZYMES) today?
The share price of ADVENZYMES as on 5th December 2025 is ₹311.20. The stock prices are volatile and keep changing through the day depending upon various factors and market conditions.What is the return on Advanced Enzyme Technologies Ltd (ADVENZYMES) share?
The past returns of Advanced Enzyme Technologies Ltd (ADVENZYMES) share are- Past 1 week: -0.49%
- Past 1 month: -1.82%
- Past 3 months: -8.20%
- Past 6 months: 2.08%
- Past 1 year: -15.96%
- Past 3 years: 10.72%
- Past 5 years: -10.31%
What are the peers or stocks similar to Advanced Enzyme Technologies Ltd (ADVENZYMES)?
The peers or stocks similar to Advanced Enzyme Technologies Ltd (ADVENZYMES) include:What is the dividend yield % of Advanced Enzyme Technologies Ltd (ADVENZYMES) share?
The current dividend yield of Advanced Enzyme Technologies Ltd (ADVENZYMES) is 1.66.What is the market cap of Advanced Enzyme Technologies Ltd (ADVENZYMES) share?
Market capitalization, short for market cap, is the market value of a publicly traded company's outstanding shares. The market cap of Advanced Enzyme Technologies Ltd (ADVENZYMES) is ₹3514.50 Cr as of 5th December 2025.What is the 52 week high and low of Advanced Enzyme Technologies Ltd (ADVENZYMES) share?
The 52-week high of Advanced Enzyme Technologies Ltd (ADVENZYMES) is ₹411.40 and the 52-week low is ₹257.90.What is the PE and PB ratio of Advanced Enzyme Technologies Ltd (ADVENZYMES) stock?
The P/E (price-to-earnings) ratio of Advanced Enzyme Technologies Ltd (ADVENZYMES) is 26.81. The P/B (price-to-book) ratio is 2.39.Which sector does Advanced Enzyme Technologies Ltd (ADVENZYMES) belong to?
Advanced Enzyme Technologies Ltd (ADVENZYMES) belongs to the Materials sector & Specialty Chemicals sub-sector.How to buy Advanced Enzyme Technologies Ltd (ADVENZYMES) shares?
You can directly buy Advanced Enzyme Technologies Ltd (ADVENZYMES) shares on Tickertape. Simply sign up, connect your demat account and place your order.
Advanced Enzyme Technologies Ltd
ADVENZYMES Share Price
ADVENZYMES Stock Scorecard
Performance
LowHasn't fared well - amongst the low performers
Valuation
HighSeems to be overvalued vs the market average
Growth
LowLagging behind the market in financials growth
Profitability
HighShowing good signs of profitability & efficiency
Entry point
GoodThe stock is underpriced and is not in the overbought zone
Red flags
LowNo red flag found
How to use scorecard? Learn more
ADVENZYMES Performance & Key Metrics
ADVENZYMES Performance & Key Metrics
| No LabelNo Label | PB RatioPB Ratio | Dividend YieldDiv. Yield |
|---|---|---|
| 23.85 | 2.39 | 1.66% |
| Sector PESector PE | Sector PBSector PB | Sector Div YldSctr Div Yld |
|---|---|---|
| 27.82 | 3.18 | 1.63% |
from 1 analyst
Price Upside
Earnings Growth
Rev. Growth
ADVENZYMES Company Profile
Advanced Enzyme Technologies is engaged in the research and development, manufacturing and marketing of over 400 products developed from over 60 indigenous enzymes.
ADVENZYMES Sentiment Analysis
ADVENZYMES Sentiment Analysis
ADVENZYMES Stock Summary · August 2025
In Q1 FY '26, the company achieved a remarkable 20% year-on-year revenue growth, driven primarily by strong performance in the Human and Animal Healthcare segments, despite facing challenges from tariffs and competitive pricing pressures that have impacted gross margins. The establishment of a new subsidiary in the nutrition and wellness sector reflects a strategic pivot towards consumer products, while ongoing R&D investments underscore a commitment to innovation, particularly in biocatalysis. However, management remains cautious about future growth, emphasizing the need for a distinct strategy in the B2C market and the importance of navigating complex market dynamics. As the company aims for 80% capacity utilization within two years, it is also addressing the challenges of converting patent interest into tangible sales, particularly in the European market. Overall, while optimism persists regarding growth opportunities, the landscape remains fraught with uncertainties that could influence operational performance.
ADVENZYMES Stock Growth Drivers
ADVENZYMES Stock Growth Drivers
7Strong Financial Performance
The company reported its highest-ever quarterly revenue of INR 185.9 crores (INR 1,859 million) for
Segment Growth and Diversification
The Human Healthcare and Animal Healthcare segments drove robust performance, with the Animal Healthcare segment
ADVENZYMES Stock Challenges
ADVENZYMES Stock Challenges
5Decline in EBITDA Margins
The company has experienced a significant decline in EBITDA margins, which have decreased from over
Challenges in Gross Margins
Gross margins have decreased from historically high levels of over 75% to around 72-73% due
ADVENZYMES Forecast
ADVENZYMES Forecasts
Price
Revenue
Earnings
ADVENZYMES Share Price Forecast
ADVENZYMES Share Price Forecast
All values in ₹
All values in ₹
ADVENZYMES Company Revenue Forecast
ADVENZYMES Company Revenue Forecast
All values in ₹ cr.
All values in ₹ cr.
ADVENZYMES Stock EPS (Earnings Per Share) Forecast
ADVENZYMES Stock EPS (Earnings Per Share) Forecast
All values in ₹
All values in ₹
ADVENZYMES
ADVENZYMES
Income
Balance Sheet
Cash Flow
ADVENZYMES Income Statement
ADVENZYMES Income Statement
| Financial Year | FY 2017 | FY 2018 | FY 2019 | FY 2020 | FY 2021 | FY 2022 | FY 2023 | FY 2024 | FY 2025 | TTM | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | 331.57 | 392.41 | 424.63 | 449.63 | 510.69 | 535.80 | 566.10 | 660.53 | 669.95 | 742.29 | ||||||||||
| Raw Materials | 70.14 | 80.33 | 65.95 | 90.83 | 100.21 | 130.32 | 127.53 | 155.47 | 161.96 | 489.39 | ||||||||||
| Power & Fuel Cost | 12.87 | 18.10 | 19.29 | 19.37 | 21.45 | 29.95 | 38.10 | 41.51 | 38.45 | |||||||||||
| Employee Cost | 50.70 | 68.60 | 80.23 | 80.19 | 87.11 | 103.96 | 114.80 | 127.78 | 141.54 | |||||||||||
| Selling & Administrative Expenses | 25.61 | 38.41 | 40.04 | 37.58 | 37.72 | 51.80 | 56.22 | 59.96 | 64.17 | |||||||||||
| Operating & Other expenses | 18.00 | 20.64 | 30.84 | 12.65 | 22.78 | 10.77 | 50.56 | 48.63 | 35.28 | |||||||||||
| EBITDA | 154.25 | 166.33 | 188.28 | 209.01 | 241.42 | 209.00 | 178.89 | 227.18 | 228.55 | 252.90 | ||||||||||
| Depreciation/Amortization | 12.76 | 18.30 | 21.12 | 25.78 | 28.72 | 34.98 | 35.03 | 35.24 | 36.56 | 38.75 | ||||||||||
| PBIT | 141.49 | 148.03 | 167.16 | 183.23 | 212.70 | 174.02 | 143.86 | 191.94 | 191.99 | 214.15 | ||||||||||
| Interest & Other Items | 4.43 | 9.06 | 5.20 | 4.08 | 2.57 | 2.96 | 3.48 | 4.12 | 4.63 | 3.23 | ||||||||||
| PBT | 137.06 | 138.97 | 161.96 | 179.15 | 210.13 | 171.06 | 140.38 | 187.82 | 187.36 | 210.92 | ||||||||||
| Taxes & Other Items | 45.51 | 48.91 | 50.90 | 49.87 | 64.21 | 51.48 | 34.75 | 54.52 | 56.26 | 63.54 | ||||||||||
| Net Income | 91.55 | 90.06 | 111.06 | 129.28 | 145.92 | 119.58 | 105.63 | 133.30 | 131.10 | 147.38 | ||||||||||
| EPS | 2.79 | 8.07 | 9.95 | 11.58 | 13.06 | 10.70 | 9.45 | 11.92 | 11.72 | 13.17 | ||||||||||
| DPS | 0.08 | 0.50 | 0.60 | 0.60 | 0.90 | 1.00 | 1.00 | 5.10 | 5.20 | 5.20 | ||||||||||
| Payout ratio | 0.03 | 0.06 | 0.06 | 0.05 | 0.07 | 0.09 | 0.11 | 0.43 | 0.44 | 0.39 |
ADVENZYMES Company Updates
Investor Presentation
ADVENZYMES Stock Peers
ADVENZYMES Past Performance & Peer Comparison
ADVENZYMES Past Performance & Peer Comparison
MaterialsSpecialty Chemicals
Valuation
Technical
Forecast
| Stock | PE RatioPE Ratio | PB RatioPB Ratio | Div. YieldDividend Yield |
|---|---|---|---|
| Advanced Enzyme Technologies Ltd | 26.81 | 2.39 | 1.66% |
| Gujarat Fluorochemicals Ltd | 67.36 | 5.04 | 0.09% |
| Navin Fluorine International Ltd | 102.36 | 11.25 | 0.12% |
| Vinati Organics Ltd | 40.13 | 5.82 | 0.48% |
ADVENZYMES Stock Price Comparison
Compare ADVENZYMES with any stock or ETFADVENZYMES Holdings
ADVENZYMES Shareholdings
ADVENZYMES Promoter Holdings Trend
ADVENZYMES Promoter Holdings Trend
In last 6 months, promoter holding in the company has almost stayed constant
Pledged promoter holdings is insignificant
ADVENZYMES Institutional Holdings Trend
ADVENZYMES Institutional Holdings Trend
In last 3 months, retail holding in the company has almost stayed constant
In last 3 months, foreign institutional holding of the company has increased by 1.96%
ADVENZYMES Shareholding Pattern
ADVENZYMES Shareholding Pattern
ADVENZYMES Shareholding History
ADVENZYMES Shareholding History
Mutual Funds Invested in ADVENZYMES
Mutual Funds Invested in ADVENZYMES
No mutual funds holding trends are available
Top 5 Mutual Funds holding Advanced Enzyme Technologies Ltd
| Funds (Top 5) | The rupee value of the stock held by the fund divided by the stock’s market cap Market-cap held | Percentage of the fund’s portfolio invested in the stock Weight | Change in the portfolio weight of the stock over the last 3 months 3M holding change | The rank of the stock in the fund’s portfolio based on its weight in the portfolio along with the change in the rank over the last 3 months Portfolio rank(3M change) |
|---|---|---|---|---|
The rupee value of the stock held by the fund divided by the stock’s market cap 0.1443% | Percentage of the fund’s portfolio invested in the stock 0.19% | Change in the portfolio weight of the stock over the last 3 months -0.03% | The rank of the stock in the fund’s portfolio based on its weight in the portfolio along with the change in the rank over the last 3 months 91/295 (+3) | |
The rupee value of the stock held by the fund divided by the stock’s market cap 0.0596% | Percentage of the fund’s portfolio invested in the stock 0.12% | Change in the portfolio weight of the stock over the last 3 months 0.12% | The rank of the stock in the fund’s portfolio based on its weight in the portfolio along with the change in the rank over the last 3 months 118/144 (-99) | |
The rupee value of the stock held by the fund divided by the stock’s market cap 0.0007% | Percentage of the fund’s portfolio invested in the stock 0.01% | Change in the portfolio weight of the stock over the last 3 months -0.00% | The rank of the stock in the fund’s portfolio based on its weight in the portfolio along with the change in the rank over the last 3 months 646/795 (+1) |
Compare 3-month MF holding change on Screener
smallcases containing ADVENZYMES stock
smallcases containing ADVENZYMES stock
Looks like this stock is not in any smallcase yet.
ADVENZYMES Events
ADVENZYMES Events
ADVENZYMES Dividend Trend
ADVENZYMES has increased or maintained dividend levels over the last 5 years
Current dividend yield is 1.66%. An investment of ₹1,000 in the stock is expected to generate dividend of ₹16.55 every year
Dividends
Corp. Actions
Announcements
Legal Orders
ADVENZYMES Dividend Trend
ADVENZYMES has increased or maintained dividend levels over the last 5 years
Current dividend yield is 1.66%. An investment of ₹1,000 in the stock is expected to generate dividend of ₹16.55 every year
ADVENZYMES Upcoming Dividends
ADVENZYMES Upcoming Dividends
No upcoming dividends are available
ADVENZYMES Past Dividends
ADVENZYMES Past Dividends
Cash Dividend
Ex DateEx DateJul 23, 2025
Dividend/Share
₹1.20
Ex DateEx Date
Jul 23, 2025
Cash Dividend
Ex DateEx DateMay 16, 2025
Dividend/Share
₹4.00
Ex DateEx Date
May 16, 2025
Cash Dividend
Ex DateEx DateJul 18, 2024
Dividend/Share
₹1.10
Ex DateEx Date
Jul 18, 2024
Cash Dividend
Ex DateEx DateMay 17, 2024
Dividend/Share
₹4.00
Ex DateEx Date
May 17, 2024
Cash Dividend
Ex DateEx DateAug 4, 2023
Dividend/Share
₹1.00
Ex DateEx Date
Aug 4, 2023
ADVENZYMES Stock News & Opinions
ADVENZYMES Stock News & Opinions
Total expenditure for the period under review added up to Rs 135.27 crore, up 19.2% YoY. This was primarily due to higher raw material costs (up 24.8% YoY), higher employee expenses (up 10.8% YoY) and higher other expenses (up 14.3% YoY). Profit before tax in Q2 FY26 stood at Rs 59.54 crore, up by 41% from Rs 42.21 crore recorded in Q2 FY25. Advanced Enzyme Technologies is a research driven company with global leadership in the manufacturing of enzymes and probiotics. The company provides eco-safe solutions to a wide variety of industries like human health care and nutrition, animal nutrition, baking, fruit & vegetable processing, brewing & malting, grain processing, protein modification, dairy processing, specialty applications, textile processing and others. Its aim is to replace traditionally used chemicals with eco-friendly enzymatic solutions. Powered by Capital Market - Live
Net profit of Advanced Enzyme Technologies rose 31.98% to Rs 43.33 crore in the quarter ended September 2025 as against Rs 32.83 crore during the previous quarter ended September 2024. Sales rose 26.30% to Rs 184.53 crore in the quarter ended September 2025 as against Rs 146.10 crore during the previous quarter ended September 2024. ParticularsQuarter EndedSep. 2025Sep. 2024% Var. Sales184.53146.10 26 OPM %32.5529.03 - PBDT69.6251.10 36 PBT59.5442.21 41 NP43.3332.83 32 Powered by Capital Market - Live
Advanced Enzyme Techs. will hold a meeting of the Board of Directors of the Company on 12 November 2025.Powered by Capital Market - Live
Advanced Enzyme Technologies has allotted 45,650 equity shares under ESOP. Consequent to the said allotment, the paid-up share capital of the Company stands increased from Rs 22,37,62,300 comprising of 11,18,81,150 equity shares of Rs 2 each to Rs 22,38,53,600 comprising of 11,19,26,800 equity shares of Rs 2 each. Powered by Capital Market - Live
Relaxo Footwears Ltd, Apollo Micro Systems Ltd, Granules India Ltd and Godfrey Phillips India Ltd are among the other gainers in the BSE's 'A' group today, 29 August 2025.Advanced Enzyme Technologies Ltd spiked 8.42% to Rs 351.5 at 11:45 IST. The stock was the biggest gainer in the BSE's 'A' group. On the BSE, 9.8 lakh shares were traded on the counter so far as against the average daily volumes of 62622 shares in the past one month. Relaxo Footwears Ltd surged 7.06% to Rs 478.95. The stock was the second biggest gainer in 'A' group. On the BSE, 1.05 lakh shares were traded on the counter so far as against the average daily volumes of 35687 shares in the past one month. Apollo Micro Systems Ltd soared 6.93% to Rs 259.3. The stock was the third biggest gainer in 'A' group. On the BSE, 36.02 lakh shares were traded on the counter so far as against the average daily volumes of 12.89 lakh shares in the past one month. Granules India Ltd rose 6.85% to Rs 499.35. The stock was the fourth biggest gainer in 'A' group. On the BSE, 2.79 lakh shares were traded on the counter so far as against the average daily volumes of 70472 shares in the past one month. Godfrey Phillips India Ltd gained 6.42% to Rs 11276.5. The stock was the fifth biggest gainer in 'A' group. On the BSE, 66205 shares were traded on the counter so far as against the average daily volumes of 55906 shares in the past one month. Powered by Capital Market - Live
Shakti Pumps (India) Ltd, Neogen Chemicals Ltd, Balaji Amines Ltd and Thermax Ltd are among the other losers in the BSE's 'A' group today, 04 August 2025.Advanced Enzyme Technologies Ltd crashed 8.54% to Rs 329.5 at 14:46 IST.The stock was the biggest loser in the BSE's 'A' group.On the BSE, 92278 shares were traded on the counter so far as against the average daily volumes of 32674 shares in the past one month.Shakti Pumps (India) Ltd tumbled 6.78% to Rs 832.95. The stock was the second biggest loser in 'A' group.On the BSE, 3.43 lakh shares were traded on the counter so far as against the average daily volumes of 47449 shares in the past one month.Neogen Chemicals Ltd lost 6.35% to Rs 1439.85. The stock was the third biggest loser in 'A' group.On the BSE, 3976 shares were traded on the counter so far as against the average daily volumes of 1365 shares in the past one month.Balaji Amines Ltd plummeted 6.28% to Rs 1584.7. The stock was the fourth biggest loser in 'A' group.On the BSE, 14808 shares were traded on the counter so far as against the average daily volumes of 7595 shares in the past one month.Thermax Ltd shed 6.01% to Rs 3549.7. The stock was the fifth biggest loser in 'A' group.On the BSE, 7331 shares were traded on the counter so far as against the average daily volumes of 14343 shares in the past one month.Powered by Capital Market - Live
Net profit of Advanced Enzyme Technologies rose 16.93% to Rs 39.93 crore in the quarter ended June 2025 as against Rs 34.15 crore during the previous quarter ended June 2024. Sales rose 20.31% to Rs 185.91 crore in the quarter ended June 2025 as against Rs 154.52 crore during the previous quarter ended June 2024. ParticularsQuarter EndedJun. 2025Jun. 2024% Var. Sales185.91154.52 20 OPM %30.3533.12 - PBDT64.5257.29 13 PBT54.9048.67 13 NP39.9334.15 17 Powered by Capital Market - Live
Advanced Enzyme Techs. will hold a meeting of the Board of Directors of the Company on 2 August 2025.Powered by Capital Market - Live
Advanced Enzyme Technologies has fixed 17 May 2025 as record date for payment of interim dividend of Rs 4 per equity share for FY 2025-26. The dividend will be paid on or before 10 June 2025. Powered by Capital Market - Live
Advanced Enzyme Techs. announced that the 36th Annual General Meeting(AGM) of the company will be held on 30 July 2025.Powered by Capital Market - Live
Over the last 5 years, revenue has grown at a yearly rate of 8.3%, vs industry avg of 11.01%
Over the last 5 years, market share decreased from 0.84% to 0.68%
Over the last 5 years, net income has grown at a yearly rate of 0.28%, vs industry avg of 7.61%